Business
MedMira Showcases its Multiplo Line of Rapid Tests at the 2014 STD Prevention Conference
Company to Demonstrate How its Multiplo Rapid Tests can Maximize Impact, Efficiency and R...
About this update from Medmira Inc.
[{"type":"text","content":"\n\n\nCompany to Demonstrate How its Multiplo Rapid Tests can Maximize Impact,\n Efficiency and Return on Program Investments \n\n\nHALIFAX, June 10, 2014 /CNW/ - MedMira Inc. (TSXV: MIR) will showcase its rapid HIV, hepatitis and syphilis multiplex test to more than 1,500\n sexually transmitted disease (STD) and HIV experts this week at the\n 2014 STD Prevention Conference in Atlanta, GA. This biennial event,\n which concentrates on domestic and international STD prevention\n initiatives, gives community organizations, individuals, public health\n professionals, clinicians, and advocates the opportunity to exchange\n information about effective prevention. The theme for this year's\n conference is \"More STD Prevention for the Money: Maximizing Impact,\n Efficiency and Return on Program Investments.\"\n\n\nMedMira's Multiplo™ rapid diagnostics are built on the Company's\n patented Rapid Vertical Flow Technology™, which enables the simultaneously delivery of multiple tests results on\n a single test cartridge with one drop of specimen, saving healthcare\n providers and their patients time and money. These tests are extremely\n advantageous for diagnosing and treating populations at risk of\n multiple infections, such as HIV and hepatitis, which share similar\n transmission routes and impact treatment outcomes. They also benefit\n those whose access to care may be limited, and who may easily be lost\n to follow-up.\n\n\n\"Delivering multiple test results in a single visit is to everyone's\n advantage in STD prevention. Both the healthcare provider and the\n patients can benefit from reduced time and costs, and quicker access to\n the right course of treatment,\" said Neeraj Vats, Director of\n Technology and Business Affairs, MedMira Inc. \"Our technology, and the\n multiplexing capabilities it delivers, creates opportunities for\n program managers and care providers to expand or combine existing\n testing programs dedicated to just one disease to encompass multiple\n diseases. They can triple the number of results they deliver without\n having to triple resources, testing time, and cost.\"\n\n\nMedMira will present results illustrating that the performance of its\n rapid, easy-to-use screening/diagnostic tool, Multiplo Rapid HBc/HIV/HCV Antibody Test, is comparable to conventional laboratory methods for early detec...